Long-term follow-up of endovascular treatment for trans-Atlantic inter-society consensus II type B Iliac lesions in patients aged <50 years.
Ann Vasc Surg
; 26(8): 1057-63, 2012 Nov.
Article
em En
| MEDLINE
| ID: mdl-22410143
ABSTRACT
BACKGROUND:
To study the initial and long-term results of endovascular treatment in patients aged <50 years with trans-Atlantic inter-society consensus-II type B unilateral iliac lesions and chronic limb ischemia.METHODS:
From January 2000 to February 2010, 60 consecutive endovascular interventions were performed on 23 women and 37 men aged ≤50 years. After successful treatment, all patients were followed up at 1, 3, 6, and 12 months after the procedure and every 6 months thereafter.RESULTS:
Successful percutaneous revascularization of the iliac artery was achieved in 56 patients (93.3%). The early vascular-related complication rate was 6.7%. The primary patency rates at 1, 3, and 5 years were 88%, 59%, and 49%, respectively. Cox univariate analysis revealed that an age range of 45 to 50 years (hazard ratio [HR] 0.290; 95% confidence interval [CI] 0.152-0.553; P = 0.0001), lower preprocedural ankle-brachial index (HR 2.438; 95% CI 1.04-5.715; P = 0.047), lesion length >5 cm (HR 0.838; 95% CI 0.746-0.943; P = 0.003), and diabetes (HR 2.005; 95% CI 1.010-3.980; P = 0.047) had significant influence on decreasing primary patency.CONCLUSIONS:
Endovascular treatment of TASC-II type B iliac lesions in patients aged <50 years is a safe procedure with low procedural risk. Primary patency rates at 1, 3, and 5 years were 88%, 59%, and 49%, respectively.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Angioplastia com Balão
/
Doença Arterial Periférica
/
Artéria Ilíaca
/
Isquemia
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article